MENU
+Compare
NLSP
Stock ticker: NASDAQ
AS OF
Jan 30, 04:59 PM (EDT)
Price
$1.99
Change
+$0.03 (+1.53%)
Capitalization
5.72M

NLSP Nls Pharmaceutics Ltd Forecast, Technical & Fundamental Analysis

Industry Biotechnology
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NLSP with price predictions
Jan 29, 2025

NLSP sees its Stochastic Oscillator climbs out of oversold territory

On January 29, 2025, the Stochastic Oscillator for NLSP moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NLSP advanced for three days, in of 185 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NLSP as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NLSP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (15.749). P/E Ratio (0.000) is within average values for comparable stocks, (88.784). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.848). NLSP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (276.027).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NLSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NLSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
The Circle 6
Phone
+41 445122150
Employees
2
Web
https://www.nlspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DVA176.502.73
+1.57%
DaVita
THM0.480.01
+1.25%
International Tower Hill Mines Ltd
FULT20.35-0.13
-0.63%
Fulton Financial Corp
ONVO0.35-0.01
-1.44%
Organovo Holdings
ABUS3.30-0.08
-2.37%
Arbutus Biopharma Corp

NLSP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NLSP has been loosely correlated with GRI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NLSP jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NLSP
1D Price
Change %
NLSP100%
+4.26%
GRI - NLSP
38%
Loosely correlated
N/A
GOVX - NLSP
27%
Poorly correlated
-3.09%
LOGC - NLSP
25%
Poorly correlated
+3.95%
MBIO - NLSP
23%
Poorly correlated
+15.60%
RLYB - NLSP
22%
Poorly correlated
-1.86%
More